Αναφορές – References
|
1. ΚΕ.ΕΛ.Π.ΝΟ.: ΑΛΛΑΝΤΙΑΣΗ (ICD-10 A05.1) [Internet]. 2010. Available from: http://www.keelpno.gr/Portals/0/-Αρχεία/Τροφιμογενή/Αλλαντίαση/ΑΛΛΑΝΤΙΑΣΗ%20Περιγραφή.pdf
2. Heymann D. MD. Control of Communicable Diseases Manual. 19th Edition. 2008. American Public Health Association
3. Infant Botulismus Treatment and Prevention Program. Available from: http://www.infantbotulism.org/parent/prevention.php
4. Schroeter M., Alpers K., Van Treeck U., Frank C., Rosenkoetter N., Schaumann R.: Outbreak of wound botulism in injecting drug users. Epidemiol. Infect. 137: 1602-1608 (2009)
5. Chertow D.S., Tan E.T., Maslanka S.E., Schulte J., Bresnitz E.A., Weisman R.S., Bernstein J., Marcus S.M., Kumar S., Malecki J., Sobel J., Braden C.R.: Botulism in 4 adults following cosmetic injections withan unlicensed, highly concentrated botulinum preparation. JAMA 296: 2476-2479 (2008)
6. Health Protection Agency (HPA). Αvailable from: http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1203928725961
7. Centers for Disease, Control and Prevention (CDC). Αvailable from: http://www.cdc.gov/nczved/divisions/dfbmd/diseases/botulism/#complications
8. Centers for Disease, Control and Prevention (CDC). Αvailable from: http://www.cdc.gov/nczved/divisions/dfbmd/diseases/botulism/#symptoms
9. Παπαπαναγιώτου Ι.Κ., Κυριαζοπούλου-Δαλαΐνα Β.: Ιατρική μικροβιολογία & Ιολογία. 2η έκδοση, σελ. 78-79 University Studio Press, Θεσσαλονίκη, 2004
10. Smith L.: D. Botulism. The Organism, its Toxins, the Disease. Charles C Thomas Publishers, Springfield USA, 1977
11. Erbguth F.J.: Manual of botulinum toxin therapy. The pretherapeutic history of botulinum toxin, Cambridge University Press, New York, 2009
12. Kreyden O.P., Geiges M.L., Böni R., Burg G.: Botulinum toxin: from poison to drug. A historical review. Hautarzt 51: 733-737 (2000) [Άρθρο στα γερμανικά].
13. Grusser O.J.: Der Wurstkerner. Justinus Kerners Bei-trag zur Erforschung des Botulismus. In: H. Schotted., Justinus Kerner als Azt und Seelenforscher. 2nd Edition, pp. 232-256, 1998. Weinsberg: Justinus Kerner Verein, 1998
14. Steinbuch J.G.: Vergiftung durch verdorbene Wurste. Tübinger Blatter für Naturwissenschaften und Arzneikunde; Chapter 3, pp. 26-52, 1817 [Άρθρο στα γερμανικά].
15. Kerner J.: Vergiftung durch verdorbene Wurste. Tübinger Blatter für Naturwissenschaften und Arzneikunde, Chapter 3, pp. 1-25, 1817
16. Erbguth F.J.: Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov. Disord. 19 (Suppl 8): S2-6 (2004)
17. Kerner J.: Das Fettgift oder die Fettsaure und ihre Wirkungen auf den thierischen Organismus, ein Beitrag zur Untersuchung des in verdorbenen Wursten giftig wirkenden Stoffes. Cotta, Stuttgart, Tübingen, 1822
18. Erbguth F., Naumann M.: Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the sau-sage poison. Neurology 53: 1850-1853 (1999)
19. Erbguth F.: Historical note on the therapeutic use of botulinum toxin in neurological disorders. J. Neurol. Neuro-surg. Psychiatry 60: 151 (1996)
20. Erbguth F.J.: Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov. Disord. 19(Suppl. 8): S2-6 (2004)
21. Devriese P.P.: On the discovery of Clostridium botulinum. J. Hist. Neurosci. 8: 43-50 (1999)
22. Van Ermengem E.: Contribution à l’étude des Intoxications Alimentaires. Recherches sur des Accidents à Caractères Botuliniques par du Jambon. Travaux du Laboratoire d’Hygiène et de Bactériologie; 1897. Université de Gand. J. Van In & Cie, Lierre/H. Engelcke, Gand. pp. 5-269. (Extrait des Archives de Pharmacodynamie, volume III).
23. Van Ermengem E.: A new anaerobic bacillus and its relation to botulism. Rev. Infect. Dis. 1(4): 701-19 (1979). [Originally published as Über einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus. Zeitschrift für Hygiene und Infektionskrankheiten 26: 1-56 (1897)
24. Müller H.: Das Wurstgift. Deutsche Klinik, pulserial publication; 1869. Chapter 35, pp. 321-323, Chapter 37, pp. 341-343, Chapter 39, p. 357-359, Chapter 40, pp. 365-367, pp. 381-383, Chapter 49, pp. 453-455.
25. Erbguth F.J.: From poison to remedy: the chequered history of botulinum toxin. J. Neural. Transm. 115: 559-565 (2008) Epub 2007 Apr 26.
26. Snipe P.T., Sommer H.: Studies on botulinus toxin. 3. Acid preparation. J. Infect. Dis. 43: 152-160 (1928)
27. Dembek Z.F., Smith L.A., Rusnak J.M.(eds): Medical Aspects of Biological Warfare, Textbooks of Military Medicine, 2007
28. Ting P.T., Freiman A.: The story of Clostridium botulinum: from food poisoning to Botox. Clin. Med. 4: 258-261 (2004)
29. Lovell S.P.: Of Spies & Strategems. Pp. 86-88, Prentice-Hall, Englewood Cliffs, NJ, 1963
30. Schantz E.J., Johnson E.A.: Botulinum toxin: The story of its development for the treatment of human disease. Perspect. Biol. Med. 40: 317-327 (1997)
31. Biological and Toxin Weapons Convention. Apr 1971. Available from: http://www.unog.ch/80256EDD006B8954/(httpAssets)/C4048678A93B6934C1257188004848D0/$file/BWC-text-English.pdf
32. Scott A.B.: Development of botulinum toxin therapy. Dermatol Clin. 22: 131-3 (2004)
33. Scott A.B., Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest. Ophthalmol. 12: 924-927 (1973)
34. Scott A.B.: Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J. Pediatr. Ophthalmol. Strabismus 17: 21-25 (1980)
35. Lee J., Harris S., Cohen J., Cooper K., MacEwen C., Jones S.: Results of a prospective randomized trial of Botilinum Toxin therapy in acute unilateral sixth nerve palsy. J. Pediatr. Ophthalmol. Strabismus 31: 283-286 (1994)
36. Holmes J.M., Beck R.W., Kip K.E., Droste P.J., Leske D.A., and the Pediatric Eye Disease Investigator Group (PEDIG): Botilinum Toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis. J. AAPOS 4: 145-149 (2000)
37. Pratt L.A., Estanol B.: Treatment of acute paralysis of fourth cranial nerve by botulinum toxin chemodenervation. Binocul. Vis. 9: 155 (1994)
38. Carden S.M.: Botulinum Toxin chemodenervation of the inferior oblique muscle for chronic and acute IV nerve pal-sies: Results in 15 cases. Binocul. Vis. Strabismus Q. 13: 8 (1998)
39. Campos E.C., Schiavi C., Bellusci C.: Critical age of Botilinum Toxin treatment in essential infantile esotropia. J. Pediatr. Ophthalomol. Strabismus 36: 328-332 (2000)
40. McNeer K.W., Tucker M.G.: Botilinum Toxin injection into the medial rectus muscle for high accommodative convergence/accommodation esotropia. Invest. Ophthalmol. Vis. Sci. 30: 1989
41. Dawson E.L.M., Marshman W.E., Adams G.G.W.: The role of Botilinum Toxin A in acute-onset esotropia. Ophthalmology 106: 1727-1730 (1999)
42. Spencer R.F., Tucker M.G., Choo K.Y., Mc Neer K.W.: Botilinum Toxin management of childhood intermittent exotropia. Ophthalmology 104: 1762-1767 (1997)
43. Dawson E.L.M., Marshman W.E., Lee J.P.: Role of Botulinum Toxin A in surgically overcorrected exotropia. J. AAPOS 3: 269-271 (1999)
44. Carruthers J.D., Kennedy R.A., Bagaric D.: Botulinum vs adjustable suture surgery in the treatment of horizontal misalignment in adult patients lacking fusion. Arch. Oph-thalmol. 108: 1432-1435 (1990)
45. Scott A.B.: Botulinum treatment of strabismus following retinal detachment surgery. Arch. Ophthalmol. 108: 509-510 (1990)
46. Gair E.J., Lee J.P., Boo-Kian Khoo, Maurino V.: What is the role of Botilinum Toxin in the treatment of dysthyroid strabismus? J. AAPOS 3: 272-274 (1999)
47. Lyons C.J., Vickers S.F., Lee J.P.: Botilinum Toxin therapy in dysthyroid strabismus. Eye (Lond) 4(Pt 4): 538-542 (1990)
48. Λαλιώτης N.: Εγχύσεις αλλαντικής τοξίνης στην αντιμετώπιση της εγκεφαλικής παράλυσης. Ορθοπεδική 20(2): (2007)
49. Μυρωνίδου-Τζουβελέκη Μ., Τσαρτσάλης Σ.: Η χρήση της αλλαντικής τοξίνης στην αντιμετώπιση των σπαστικών διαταραχών στην εγκεφαλική παράλυση. Aristotle University Medical Journal 36(Supl.): 156 (2009)
50. FDA NEWS RELEASE. FDA approves Botox to treat chronic migraine. Oct. 15, 2010. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2010/ucm229782.htm
51. FDA NEWS RELEASE. FDA approves Botox to treat specific form of urinary incontinence. August 25, 2011. Available from:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm269509.htm
52. Carruthers A., Carruthers J.: The history of the cosmetic use of botulinum A exotoxin. Dermatol. Surg. 24: 1168-1170 (1998)
53. Carruthers A., Kiene K., Carruthers J.: Botulinum A exotoxin use in clinical dermatology. J. Am. Acad. Dermatol. 34(5 Pt 1): 788-797 (1996)
54. Schantz E.J., Johnson E.A.: Botulinum toxin: the story of its development for the treatment of human disease. Perspect. Biol. Med. 40: 317-327 (1997)
|